Journal of Gastroenterology

, Volume 45, Issue 1, pp 17–23 | Cite as

Increased expression of miR-421 in human gastric carcinoma and its clinical association

  • Zhen Jiang
  • Junming Guo
  • Bingxiu Xiao
  • Ying Miao
  • Rong Huang
  • Dong Li
  • Yuanyuan Zhang
Original Article—Alimentary Tract



Gastric cancer is a worldwide cancer with poor prognosis. Identification of diagnostic biomarkers and effective therapeutic targets is important in the treatment and diagnosis of gastric cancer. Recently, researchers have found that microRNAs play several important roles in carcinogenesis. The purpose of this study was to investigate the relationships between miR-421 expression patterns in human gastric cancer tissues with clinicopathological features.


Sixty gastric carcinoma and 18 non-tumor tissues were collected from the Secondary Hospital of Ningbo, China. For quantitative detection of the expression level of miR-421, total RNA was extracted and then reverse transcription-polymerase chain reaction was performed. The relationship between miR-421 expression in gastric cancer and clinicopathological features was analyzed. After miR-421 inhibitor was transfected into gastric cancer cells, cell growth was measured by MTT assay. Finally, the expression of its target genes was detected by Western blotting.


The miR-421 was over-expressed in 73.33% (44/60) of the gastric cancer samples examined. Over-expression of miR-421 in gastric cancer tissues was not found associated with clinicopathological features. The positive detection rate of miR-421 was higher than that of serum carcino-embryonic antigen (χ2 = 39.811, P < 0.001). Inhibition of miR-421 expression decreased the growth of both MGC-803 and SGC-7901 gastric cancer cells in vitro, with up-regulating the expression of its cancer-related target genes, CBX7 and RBMXL1.


miR-421 may involve in the early stage of stomach carcinogenesis and could be used as an efficient diagnostic biomarker.


Gastric cancer miR-421 RT-PCR Gene diagnosis 


  1. 1.
    Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMedGoogle Scholar
  2. 2.
    Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulated the proapoptotic gene hid in Drosophila. Cell. 2003;113:25–36.CrossRefPubMedGoogle Scholar
  3. 3.
    Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029–33.CrossRefPubMedGoogle Scholar
  4. 4.
    Xu P, Vernooy SY, Guo M, Hay BA. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol. 2003;13:790–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.CrossRefPubMedGoogle Scholar
  6. 6.
    Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75:855–62.CrossRefPubMedGoogle Scholar
  7. 7.
    Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.CrossRefPubMedGoogle Scholar
  9. 9.
    Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.CrossRefPubMedGoogle Scholar
  10. 10.
    Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99:15524–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Guo JM, Miao Y, Xiao BX, Huan R, Jiang Z, Meng D, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24:652–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Sobin LH, Wittekind CH. TNM classification of malignant tumors. 5th ed. New York: Wiley; 1997. p. 59–62.Google Scholar
  13. 13.
    Solcia E, Capella C. Endocrine tumours of the gastrointestinal tract. In: Solcia E, Klöppel G, Sobin LH, editors. Histological typing of endocrine tumours. 2nd ed. Berlin: Springer; 2000. p. 61–8.Google Scholar
  14. 14.
    Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta. 2009;400:97–102.CrossRefPubMedGoogle Scholar
  15. 15.
    Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Peng JJ, Cai SJ, Lu HF, Cai GX, Lian P, Guan ZQ, et al. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. World J Gastroenterol. 2007;13:3009–15.PubMedGoogle Scholar
  17. 17.
    Cummins JM, He Y, Leary RJ, Pushkaran B, Liggins AP, Pulford Kl, et al. The colorectal microRNAome. Proc Natl Acad Sci USA. 2006;103:3687–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–14.CrossRefPubMedGoogle Scholar
  19. 19.
    Cui XY, Guo YJ, Yao HR. Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:1813–5.PubMedGoogle Scholar
  20. 20.
    Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Scott CL, Gil J, Hernando E, ewer A, Iovino N, Aravin A, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci USA. 2007;104:5389–94.CrossRefPubMedGoogle Scholar
  22. 22.
    Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene. 2005;24:5543–51.CrossRefPubMedGoogle Scholar
  23. 23.
    Chao TF, Zhang Y, Yan XQ, Yin B, Gong Y-H, Yuan J-G, et al. MiR-9 regulates the expression of CBX7 in human glioma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008;30:268–74.PubMedGoogle Scholar
  24. 24.
    Hinz S, Kempkensteffen C, Christoph F, Yin B, Gong Y-H, Yuan J-G, et al. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol. 2008;29:323–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Allante P, Federico A, Berlingieri MT, Bianco M, Ferraro A, Forzati F, et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res. 2008;68:6770–8.CrossRefGoogle Scholar
  26. 26.
    Martínez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R, et al. Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem. 2006;97:1275–82.CrossRefPubMedGoogle Scholar
  27. 27.
    Su JL, Yang CY, Shih JY, Wei LH, Hsieh CY, Jeng YN, et al. Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma. Cancer Res. 2006;66:2553–61.CrossRefPubMedGoogle Scholar
  28. 28.
    Eckerich C, Zapf S, Ulbricht U, Muller S, Fillbrandt R, Westphal M, et al. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects. Glia. 2006;53:1–12.CrossRefPubMedGoogle Scholar
  29. 29.
    Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272–86.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Zhen Jiang
    • 1
  • Junming Guo
    • 1
  • Bingxiu Xiao
    • 1
  • Ying Miao
    • 1
    • 2
  • Rong Huang
    • 1
    • 2
  • Dong Li
    • 1
  • Yuanyuan Zhang
    • 1
  1. 1.Institute of Biochemistry and Molecular BiologyNingbo University School of MedicineNingboChina
  2. 2.Division of Pathology, The Affiliated HospitalNingbo University School of Medicine, and the Secondary Hospital of NingboNingboChina

Personalised recommendations